Synonyms: | |
Status: | Approved (1952) |
Entry Type: | Small molecule |
Molecule Category: | Parent |
UNII: | Q573I9DVLP |
InChI Key | VVIAGPKUTFNRDU-ABLWVSNPSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C20H23N7O7 |
Molecular Weight | 473.45 |
AlogP | -0.73 |
Hydrogen Bond Acceptor | 9.0 |
Hydrogen Bond Donor | 7.0 |
Number of Rotational Bond | 10.0 |
Polar Surface Area | 219.84 |
Molecular species | ACID |
Aromatic Rings | 2.0 |
Heavy Atoms | 34.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Oxidoreductase
|
- | - | - | 2370 | - | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC19 family of vitamin transporters
|
- | - | - | - | 60 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
Nasopharyngeal Neoplasms | 3 | D009303 | ClinicalTrials |
Colorectal Neoplasms | 3 | D015179 | ClinicalTrials |
Stomach Neoplasms | 2 | D013274 | ClinicalTrials |
Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
Pancreatic Neoplasms | 2 | D010190 | ClinicalTrials |
Stomach Neoplasms | 2 | D013274 | ClinicalTrials |
Biliary Tract Neoplasms | 2 | D001661 | ClinicalTrials |
Stomach Neoplasms | 2 | D013274 | ClinicalTrials |
Carcinoma, Hepatocellular | 2 | D006528 | ClinicalTrials |
Adenocarcinoma | 2 | D000230 | ClinicalTrials |
Stomach Neoplasms | 2 | D013274 | ClinicalTrials |
Rectal Neoplasms | 2 | D012004 | ClinicalTrials |
Biliary Tract Diseases | 2 | D001660 | ClinicalTrials |
Arthritis, Rheumatoid | 1 | D001172 | ClinicalTrials |
Neoplasms | 1 | D009369 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 58-05-9 |
ChEBI | 15640 |
ChEMBL | CHEMBL1679 |
DrugBank | DB00650 |
DrugCentral | 1232 |
EPA CompTox | DTXSID0048216 |
FDA SRS | Q573I9DVLP |
Guide to Pharmacology | 4816 |
PharmGKB | PA450198 |
PubChem | 135403648 |
SureChEMBL | SCHEMBL8349 |